Stage D prostatic carcinoma. Survival rate in relapsed patients following new forms of palliation.
作者信息
Welvaart K, Merrin C E, Mittelman A, Murphy G P
出版信息
Urology. 1974 Sep;4(3):283-6. doi: 10.1016/0090-4295(74)90378-1.
PMID:4138219
Abstract
摘要
相似文献
1
Stage D prostatic carcinoma. Survival rate in relapsed patients following new forms of palliation.D期前列腺癌。新型姑息治疗后复发患者的生存率。
Urology. 1974 Sep;4(3):283-6. doi: 10.1016/0090-4295(74)90378-1.
2
Estracyt in hormone-resistant prostatic carcinoma.雌莫司汀治疗激素抵抗性前列腺癌。
Int Urol Nephrol. 1974;6(2):101-10. doi: 10.1007/BF02082003.
3
[Preliminary results of 10 patients with advanced prostatic neoplasm treated with estracyt].[10例晚期前列腺肿瘤患者接受癌腺治治疗的初步结果]
Acta Urol Belg. 1974 Jul;42(3):326-35.
4
[Treatment of prostatic carcinoma with orally administered Estracyt].口服雌氮芥治疗前列腺癌
Ther Umsch. 1975 Feb;32(2):114-9.
5
Recent data on the mechanism of action of oestrogens in the treatment of prostatic tumour patients.雌激素治疗前列腺癌患者作用机制的最新数据。
Int Urol Nephrol. 1974;5(3):311-23. doi: 10.1007/BF02081909.
6
Pharmacoclinical study of oral estramustine phosphate (Estracyt) in advanced carcinoma of the prostate.
Invest Urol. 1974 Jul;12(1):65-8.
7
Treatment of rapidly progressing prostatic carcinoma with estracyt.用癌腺治（Estracyt）治疗快速进展性前列腺癌。
J Urol. 1972 Aug;108(2):303-6. doi: 10.1016/s0022-5347(17)60720-1.
8
[Treatment with estramustine phosphate in advanced prostatic cancer].[磷酸雌莫司汀治疗晚期前列腺癌]
Wien Med Wochenschr. 1972 Jul 22;122(30):458-60.
9
Proceedings: Cancer of the prostate.
Cancer. 1973 Nov;32(5):1089-91. doi: 10.1002/1097-0142(197311)32:5<1089::aid-cncr2820320512>3.0.co;2-i.
10
"Estracyt".雌二醇氮芥
Br J Urol. 1971 Dec;43(6):732. doi: 10.1111/j.1464-410x.1971.tb12095.x.
Zotero 插件